SPY447.17-0.71 -0.16%
DIA348.18-0.64 -0.18%
IXIC15,181.92+20.40 0.13%

BRIEF-Innovent Biologics Says Co And Genfleet Therapeutics (Shanghai) Inc Entered Into Exclusive Global License Agreement

reuters.com · 09/01/2021 21:41
BRIEF-Innovent Biologics Says Co And Genfleet Therapeutics (Shanghai) Inc Entered Into Exclusive Global License Agreement

- Innovent Biologics Inc IVBIY:

  • CO AND GENFLEET THERAPEUTICS (SHANGHAI) INC. ENTERED INTO EXCLUSIVE GLOBAL LICENSE AGREEMENT

  • GENFLEET WILL RECEIVE AN UPFRONT PAYMENT OF US$22 MILLION AT SIGNING

  • AGREEMENT FOR DEVELOPMENT AND COMMERCIALIZATION RIGHTS OF GENFLEET'S LEAD KRAS G12C INHIBITOR CANDIDATE, GFH925 IN CHINA

Source text for Eikon: ID:nHKS4QgNlf

Further company coverage: IVBIY


((Reuters.Briefs@thomsonreuters.com;))